瑞信-美股-生物科技行业-美国中小型生物科技企业专家会议纪要-2020.2.24-27页.pdf

1、 U.S. Smid Biotechnology Pulmonary Arterial Hypertension Expert Call Transcript Biotechnology | Comment We hosted a call with Dr. Vinicio de Jesus Perez, Associate Professor/Staff Physician at Stanford University, to discuss the evolving pulmonary arterial hypertension (PAH) treatment landscape. We

2、have included the full transcript in this document; additionally, see our brief summary note. Call replay dial-in: (855) 859-2056 or (404) 537-3406; Conference ID: 9349287. 24 February 2020 Equity Research Americas | United States DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DIS

3、CLOSURES, ANALYST CERTIFICATIONS, LEGAL ENTITY DISCLOSURE AND THE STATUS OF NON-US ANALYSTS. US Disclosure: Credit Suisse does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the Firm may have a conflict of interest that could affe

4、ct the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Research Analysts Martin Auster, M.D. 212 325 6573 martin.austercredit- Tiago Fauth 212 325 7569 tiago.fauthcredit- Mark Connolly 212 325 7576 mark.connollycredit- Th

5、omas Deal 212 325 3719 thomasavery.dealcredit- 每日免费获取报告1、每日微信群内分享7+最新重磅报告；2、每日分享当日华尔街日报、金融时报；3、每周分享经济学人4、行研报告均为公开版，权利归原作者所有，起点财经仅分发做内部学习。扫一扫二维码关注公号回复：研究报告加入“起点财经”微信群。 24 February 2020 U.S. Smid Biotechnology 2 *Note: We have made very minimal edits to the following transcript to correct obvious spel

6、ling errors, but have otherwise opted to leave the transcript in its original form in order to preserve the integrity of the conversation. Moderator: Marty Auster February 21, 2020 10:00 a.m. ET OPERATOR: This is Conference #: 9349287 Operator: Ladies and gentlemen, thank you for standing by. Welcom

7、e to Pulmonary Arterial Hypertension Treatment Landscape conference call. At this time, all participants are in a listen-only mode. After the speakers remarks, there will be a question and answer session. To ask a question during the session, you will need to press “star,” “1” on your telephone. If

8、you wish to remove yourself from the queue, please press the “pound” key. Please be advised that todays conference is being recorded. If you require any further assistance, please press “star,” “0.” Thank you. I would now like to hand the conference over to your host, Mr. Martin Auster of Credit Sui

9、sse. Sir, you may begin. Marty Auster: Thank you, operator. This is Marty Auster at Credit Suisse, Im the lead SMID cap biotech analyst here, and thank you for joining us in our I guess this is the second edition of Credit Suisses biotech footing, which is going to be our Friday morning conference c

10、all series that Ill be doing with my colleagues Evan Seigerman as well as my colleagues abroad, (Jo Walton) and (Trung Huynh). The idea of this call is that you work hard all week and Friday morning, were going to kind of spoon-feed you some dessert and go through a topic thats timely where were get

11、ting a bunch of questions and kind of cover and dig in a little bit deeper. Before we start today, I have a brief disclosure I need to read. I am a publishing analyst, I may use the information provided today in my research. With me on the phone are members in the investment 24 February 2020 U.S. Sm

12、id Biotechnology 3 community as well. They may use the information to make decisions on buying or selling stocks or other investments. I dont want to discuss any material (not) public information today on the call, or any information that is subject to confidentiality obligations on your part, Dr. P

13、erez. I dont want to speak if this conversation will violate your employers policies of confidential obligations you owe to anyone else. So Dr. Perez, is it OK to proceed with our call on this basis? Vinicio de Jesus Perez: Yes. Marty Auster: Excellent. So Im joined today by Dr. Perez, an associate

14、professor at Stanford University to discuss pulmonary arterial hypertension. I think maybe the right way to start then is just if you can tell us a little bit about your practice, kind of the number of patients youre treating and kind of typically how you think about managing a patient, when you typ

15、ically see them, what course (over) the disease and how do you typically kind of manage those patients on presentation? Vinicio de Jesus Perez: Well good morning everyone. As a matter of introduction, I am an associate professor of medicine at Stanford University, the (owner) hypertension center in

16、the United States. We oversee the diagnosis and care of over 2,000 patients with all forms of pulmonary hypertension. The great majority of patients that we see, (say) large referral center are group one pulmonary hypertensions, also known as pulmonary arterial hypertension. Part of our practice of course is to carry out the research we have ongoing clinical research projects in collaboration with pharmaceuticals, also federal funded projects looking at medications as well as mechanisms of (dise